GD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
GD is a good buy right now for a beginner focused on long-term investing with $50,000-$100,000 to deploy. My view is a clear BUY: the company just delivered a strong Q1, raised guidance, and is backed by favorable defense-spending catalysts. The stock is near resistance but still has constructive momentum and solid institutional/analyst support, so for an investor who is impatient and wants to act now, it is buyable here.
GD is in a short-term constructive trend but not a clean breakout yet. MACD histogram is positive and expanding, showing improving momentum. RSI_6 at 72.698 is elevated, indicating the stock is strong but somewhat stretched. The moving-average structure is bearish on the longer-to-shorter sequence (SMA_200 > SMA_20 > SMA_5), which suggests the longer-term trend is not fully confirmed above trend resistance. Price at 344.3 is just above pivot 327.322 and very close to R1 at 343.687, so the stock is testing near-term resistance. Overall, the technical picture supports a cautious-but-positive entry rather than a deeply discounted one.
Latest quarter: Q1 2026. The company posted strong operating results with revenue of $13.481 billion, up 10.29% YoY, net income of $1.125 billion, up 13.18% YoY, EPS of $4.10, up 12.02% YoY, and gross margin of 15.9%, up 2.65% YoY. The quarter was clearly growth-positive, and the raised guidance plus strong order intake indicate the growth trend is continuing into the rest of 2026.
Analyst trend is constructive overall, with several firms raising price targets after the strong Q1. Morgan Stanley raised PT to $435 and kept Overweight; JPMorgan raised PT to $400 and kept Overweight; Wells Fargo initiated Overweight at $400. On the cautious side, UBS is Neutral with PT cut to $371, Deutsche Bank downgraded to Hold with PT $387, and Jefferies/Citi are around Hold/Neutral with PTs near $380. Wall Street’s pros see strong defense and Gulfstream demand, robust backlog, and a better earnings outlook. The cons are valuation concerns and the view from some firms that growth advantages may narrow over time. Net takeaway: analyst sentiment is positive but not universally bullish.
